Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in drug discovery programs focused on oncology. The compound's functional groups enable further chemical modifications, allowing optimization of pharmacokinetic properties such as solubility and metabolic stability. It is also employed in structure-activity relationship (SAR) studies to enhance potency and selectivity of lead compounds.